全文获取类型
收费全文 | 730篇 |
免费 | 65篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 2篇 |
妇产科学 | 3篇 |
基础医学 | 22篇 |
临床医学 | 57篇 |
内科学 | 160篇 |
神经病学 | 35篇 |
特种医学 | 17篇 |
外国民族医学 | 1篇 |
外科学 | 258篇 |
综合类 | 133篇 |
预防医学 | 10篇 |
药学 | 29篇 |
中国医学 | 3篇 |
肿瘤学 | 85篇 |
出版年
2024年 | 2篇 |
2023年 | 23篇 |
2022年 | 32篇 |
2021年 | 46篇 |
2020年 | 38篇 |
2019年 | 24篇 |
2018年 | 30篇 |
2017年 | 34篇 |
2016年 | 36篇 |
2015年 | 34篇 |
2014年 | 67篇 |
2013年 | 56篇 |
2012年 | 60篇 |
2011年 | 43篇 |
2010年 | 31篇 |
2009年 | 38篇 |
2008年 | 30篇 |
2007年 | 33篇 |
2006年 | 22篇 |
2005年 | 26篇 |
2004年 | 19篇 |
2003年 | 13篇 |
2002年 | 15篇 |
2001年 | 15篇 |
2000年 | 9篇 |
1999年 | 7篇 |
1998年 | 6篇 |
1997年 | 2篇 |
1996年 | 1篇 |
1995年 | 4篇 |
1994年 | 3篇 |
1993年 | 2篇 |
1992年 | 2篇 |
1991年 | 3篇 |
1990年 | 3篇 |
1989年 | 2篇 |
1988年 | 1篇 |
1986年 | 1篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1982年 | 1篇 |
排序方式: 共有816条查询结果,搜索用时 15 毫秒
121.
目的:探讨进展期食管胃交界部腺癌(AEGJ)患者围手术期外周血中淋巴细胞亚群及CD4+CD25+T细胞和程序性细胞死亡1(PD-1)在T淋巴细胞中表达的变化,了解根治性手术创伤对机体细胞免疫功能的影响及机制。 方法:126例进展期食管胃交界部腺癌行开腹根治性R0切除+D2淋巴结清除术,同期体检志愿者87例为对照组。应用流式细胞仪检测对照组和治疗组术前、术后1天、术后3天、术后7天和术后9天外周血CD3+、CD3+CD4+、CD3+CD8+、CD4+CD25+T细胞计数和PD-1在T细胞中的表达水平。结果:治疗组术前和对照组相比较,CD3+、CD3+CD4+T细胞均显著降低(P<0.05),而CD4+CD25+T细胞和PD-1在CD4+、CD8+T细胞的表达比例均显著增高(P<0.05)。CD4+CD25+T细胞的比例在术后1天迅速下降至谷底,随后逐渐升高,于术后7天达顶峰,然后再次下降。CD4+PD-1+T细胞的比例在术后显著增加:术后第1天达到最大值,然后逐渐下降,但在术后第7天仍显著高于术前。 CD8+PD-1+T细胞的比例则在术后逐渐增加,到术后7天达高峰。结论:食管胃交界部腺癌手术创伤可能是通过各种细胞因子导致CD4+PD-1+T细胞比例改变,进而调节T淋巴细胞亚群比例,抑制细胞免疫能力。 相似文献
122.
123.
Jia-Bin Wang Man-Qiang Lin Ping Li Jian-Wei Xie Jian-Xian Lin Jun Lu Qi-Yue Chen Long-Long Cao Mi Lin Chao-Hui Zheng Chang-Ming Huang 《European journal of surgical oncology》2017,43(12):2333-2340
Background
The purpose of this study was to evaluate the prognosis of patients with Siewert type II/III adenocarcinoma of the esophagogastric junction (AEG) with parapyloric lymph node (No. 5 and 6 lymph nodes, PLN) metastasis and to determine the need for PLN dissection for patients with type II/III AEG.Methods
A total of 1008 patients with type II/III AEG who underwent a transabdominal total gastrectomy were enrolled. The long-term surgical outcome of PLN-positive patients and the therapeutic value of PLN dissection were analyzed.Results
There was no significant difference in the incidence of PLN metastasis between type II and III cancers (5.7% vs. 8.5%, P > 0.05). PLN metastasis was a significant prognostic factor for type II/III cancers (HR 1.63; P = 0.001). Among type II/III cancers, the 5-year survival of patients with PLN-positive cancers was much lower than that of patients with PLN-negative cancers (21.3% vs. 60.8%, P < 0.001). Even after radical resection, the 5-year survival of patients with stage I–III PLN-positive cancers was similar to that of patients with stage IV cancers without PLN metastasis (23.5% vs. 23.1%, P > 0.05). In the analysis of the therapeutic value of lymph node dissection in each station for type II and III cancers after radical resection, lymph nodes with the lowest therapeutic value index after No. 12a were No. 5 and 6 lymph nodes.Conclusions
Patients with type II/III AEG with PLN metastasis have a poor prognosis, similar to patients with stage IV disease. PLN dissection offers marginal therapeutic value for patients with type II/III AEG. 相似文献124.
BACKGROUND AND OBJECTIVES: It remains controversial whether cardia carcinoma should be categorized and treated as esophageal cancer or gastric cancer. The purpose of this study was to develop a reasonable definition of cardia carcinoma. METHODS: Patients with Siewert type II carcinomas were divided into two subgroups: 25 patients with a tumor center within 1 cm of the esophagogastric junction (EGJ) (type IIA) and 22 patients with tumor center 1-2 cm aboral of the EGJ (type IIB). Patients with subcardia carcinomas, 40 with invasion to the EGJ (type III) and 110 without (type IIIe-), were used as controls. RESULTS: The patients with type IIB carcinomas showed no different characteristics from those with type III or type IIIe- carcinomas, except for the stage of the disease. On the other hand, those with type IIA carcinomas were associated with a higher male/female ratio, higher incidences of elevated appearance, differentiated histology, and mediastinal node metastasis, and a significantly lower survival rate as compared with patients with subcardia carcinomas. Multivariate survival analysis revealed that type IIA is a significant prognostic determinant, but that type IIB is not. CONCLUSION: Type IIA carcinomas should be treated as true cardia carcinoma; type IIB as subcardia carcinoma. Our results should be confirmed by a prospective study. 相似文献
125.
[目的]评价PTCH1在胃食管连接部腺癌(AEG)组织中的表达及意义。[方法]选择64例AEG组织、癌旁组织标本,应用RT-PCR和Western blot方法检测标本中PTCH1mRNA和蛋白的表达情况,并分析PTCH1蛋白的表达与AEG临床病理特征的关系。[结果]与癌旁组织相比,AEG组织中PTCH1 mRNA和蛋白的表达均明显下调,差异有统计学意义(P〈0.05)。PTCH1蛋白表达与AEG患者性别、年龄、肿瘤大小和淋巴结转移无关,与肿瘤分化程度有关(P〈0.05)。[结论]PTCH1在AEG组织中低表达可能与胃食管连接处腺癌的发生、发展相关。 相似文献
126.
Xueke Ge Qun Zhao Yuzhi Song Jing Li Ming Liu Wenwen Bai Xueying Qiao 《European journal of surgical oncology》2018,44(4):502-508
Purpose
Preoperative therapy improves overall survival (OS) after surgery in patients with adenocarcinoma of the esophagogastric junction (AEG). We aimed to retrospectively analyze whether preoperative chemoradiotherapy (CRT) could improve the prognosis of patients with locally advanced Siewert II and III AEG comparing with preoperative chemotherapy alone (CT).Patients and methods
From March 2012 to December 2015, 170 patients with locally advanced (cT3-4NxM0) Siewert II and III AEG were treated with preoperative CRT or CT in Hebei Medical University Fourth Hospital, and 123 patients were included in this study to compare the effects of preoperative CRT with CT.Results
R0 resection rate was 96.7% in CRT group and 82.5% in CT group (P = .016). The pathological complete response was 16.7% after CRT group and 3.2% after CT (P = .015). The median follow-up time was 20 months. The 1- and 3-year OS were 89.4%, 79.2% in CRT group and 88.2%, 58.0% in CT group (P = .016; HR = 0.40, 95% confidence interval 0.21–0.76). The 1- and 3-year PFS were 87.3%, 73.5% in CRT group and 72.8%, 42.8% in CT group (P = .014; HR = 0.46, 95% confidence interval 0.24–0.86). Multivariate analysis showed that clinical T stage, adjuvant chemotherapy cycles and histologic differentiation were shown to be the independent prognostic factors for OS, and postoperative pathologic N stage was shown to be the independent prognostic factor for PFS.Conclusion
For the patients with locally advanced AEG, the addition of radiotherapy to preoperative chemotherapy can improve survival with safety, but is not an independent prognostic factor for OS and PFS. 相似文献127.
K. Lehmann D. Eshmuminov P. Bauerfeind C. Gubler P. Veit-Haibach A. Weber H. Abdul-Rahman M. Fischer C. Reiner P.M. Schneider 《European journal of surgical oncology》2017,43(1):196-202
Introduction
The accuracy of preoperative lymph-node staging in patients with adenocarcinoma of the esophagogastric junction (AEG) or gastric cancer (GC) is low. The aim of this study was to assess the accuracy of [18F]fluorodeoxyglucose positron emission tomography/computed tomography (PET-CT) for lymph-node staging in patients with AEG or GC, with or without neoadjuvant treatment.Patients and methods
221 consecutive patients with GC (n = 88) or AEG (n = 133) were evaluated. Initial staging included endoscopic ultrasound (EUS), multidetector spiral CT (MDCT) and PET-CT. PET-CT was performed for restaging in patients after neoadjuvant treatment (n = 94). Systematic lymphadenectomy was routinely performed with histopathological assessment of individual mediastinal and abdominal lymph-node stations. Preoperative staging from EUS, MDCT, and PET-CT was correlated with histopathological results.Results
PET-CT showed a high specificity (91%) and positive predictive value (89%) for the preoperative detection of lymph-node metastases. In comparison, EUS was more sensitive (73% versus 50%, P < 0.01) but less specific (60%, P < 0.01). In patients with intestinal/mixed-type tumors, PET-CT improved the detection of extra-regional lymph-node metastases (P = 0.01) and distant metastases (P = 0.01) compared to CT alone. In contrast, lymph-node assessment by PET/CT after neoadjuvant treatment (32%, P < 0.01) and in diffuse-type cancers (24%, P < 0.01) is futile because of low sensitivities.Conclusion
PET-CT does not improve the overall accuracy of N staging, but does improve specificity compared to EUS and MDCT in AEG and GC. We do not recommend routine PET-CT for the initial staging in patients with diffuse-type cancer or for restaging of lymph nodes after neoadjuvant treatment. 相似文献128.
Marital status,education, and income in relation to the risk of esophageal and gastric cancer by histological type and site 下载免费PDF全文
129.
目的比较经胸与经腹食管裂孔手术治疗高龄食管胃结合部腺癌患者的近期效果。方法回顾性分析2013年8月至2016年2月江南大学附属医院行食管胃结合部癌切除术92例高龄患者临床资料,其中经左胸入路(经胸组)47例,经腹正中入路(经腹组)45例。比较两组患者的一般资料及手术时间、术中出血量、淋巴结清扫数目、术后住院时间及术后并发症的发生率。结果两组患者的手术时间、术中出血量和淋巴结清扫数目无统计学差异(均P≥0.05)。与经胸组相比,经腹组患者获取阳性淋巴结数目更多[(8.1±5.0)枚 vs.(5.1±4.4)枚,t=3.000,P=0.003],术后住院时间更短[(11.7±6.9)天vs.(15.9±7.4)天,t=2.773,P=0.007)],术后并发症发生率较低(13.3% vs.44.7%,χ2=10.895,P=0.001),其中肺部感染(2.2% vs.14.9%,χ2=4.649,P=0.031)、心律失常(4.4% vs 19.1%,χ2=4.722,P=0.030)发生率均较低。两组患者的吻合口瘘、切口感染、纵膈或胸腔感染的发生率均无统计学差异(均P≥0.05)。两组患者均无切缘阳性和围术期死亡病例。结论对于心肺功能差的高龄食管胃结合部腺癌患者,经腹食管裂孔入路比经胸入路手术在对心肺功能影响较小,能够显著降低术后并发症的发生率,缩短住院时间。 相似文献
130.